Cetuximab: all 645 studies that test it

Page 2 of 7. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.

• A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell CarcinomaTerminatedNCT03254927Phase 2Results posted
• Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaCompletedNCT03082534Phase 2Results posted
• Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and NeckCompletedNCT02979977Phase 2Results posted
• Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal CancerCompletedNCT02953782Phase 1/2Results posted
• Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing SurgeryTerminatedNCT02855086Phase 1/2Results posted
• Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing SurgeryTerminatedNCT02736578Phase 2Results posted
• Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02713373Phase 1/2Results posted
• S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung CancerCompletedNCT02438722Phase 2/3Results posted
• Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck CancerCompletedNCT02383966Phase 3Results posted
• A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesCompletedNCT02327169Phase 1Results posted
• Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin CancerCompletedNCT02324608Not applicableResults posted
• A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)CompletedNCT02291289Phase 2Results posted
• Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical ResectionCompletedNCT02241187Not applicableResults posted
• Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerTerminatedNCT02177838Not applicableResults posted
• Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHNCompletedNCT02124707Phase 2Results posted
• PD 0332991 and Cetuximab in Patients With Incurable SCCHNCompletedNCT02101034Phase 1/2Results posted
• Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid TumoursCompletedNCT02020577Phase 1Results posted
• Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckCompletedNCT01979211Phase 2Results posted
• Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22TerminatedNCT01884740Phase 1/2Results posted
• PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01816984Phase 1/2Results posted
• Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck CarcinomaTerminatedNCT01794845Phase 2Results posted
• Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck CancerTerminatedNCT01790516Not applicableResults posted
• Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal CancerCompletedNCT01787006Phase 2Results posted
• Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking HistoryCompletedNCT01758731Phase 1Results posted
• Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive PatientsCompletedNCT01663259Not applicableResults posted
• Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck CancerCompletedNCT01581970Phase 2Results posted
• Cetuximab and Dasatinib in Recurrent Squamous Cell CarcinomaTerminatedNCT01488318Phase 2Results posted
• Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by SurgeryActive, not recruitingNCT01468896Phase 1/2Results posted
• Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) GenotypeCompletedNCT01450319Phase 2Results posted
• Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT01437449Phase 2Results posted
• Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT01412229Phase 2Results posted
• Cetuximab in Combination With S-1 and Cisplatin in Gastric CancerCompletedNCT01388790Phase 2Results posted
• E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and NeckCompletedNCT01332266Phase 1/2Results posted
• Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell CancerTerminatedNCT01326923Phase 2Results posted
• Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal CancerCompletedNCT01302834Phase 3Results posted
• Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01289522Phase 2Results posted
• A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck CancerCompletedNCT01283334Phase 1/2Results posted
• Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01280643Not applicableResults posted
• Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + CetuximabCompletedNCT01276379Phase 2Results posted
• Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyCompletedNCT01256385Phase 2Results posted
• Cetuximab Standard or Dose Escalation in First Line Colorectal CancerCompletedNCT01251536Phase 2Results posted
• A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type PatientsCompletedNCT01228734Phase 3Results posted
• ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01218048Phase 2Results posted
• A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and NeckCompletedNCT01177956Phase 3Results posted
• Cetuximab and Lenalidomide in Head and NeckCompletedNCT01133665Phase 2Results posted
• Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung CancerCompletedNCT01109524Phase 2Results posted
• Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT01104922Phase 2Results posted
• Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)CompletedNCT01102231Phase 2Results posted
• Study in Advanced Solid TumorsCompletedNCT01099358Phase 2Results posted
• Neo-Adjuvant Study in Triple Negative Breast Cancer PatientsCompletedNCT01097642Phase 2Results posted
• Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung CancerCompletedNCT01090011Phase 1Results posted
• A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck CancerCompletedNCT01087970Phase 2Results posted
• Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx CancerCompletedNCT01084083Phase 2Results posted
• A Study in Head and Neck CancerCompletedNCT01081041Phase 2Results posted
• A Study in Advanced Solid TumorsCompletedNCT01063075Phase 2Results posted
• A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck CancerCompletedNCT01057589Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal CancerTerminatedNCT01032291Phase 2Results posted
• Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese SubjectsCompletedNCT01012258Phase 3Results posted
• RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHNTerminatedNCT01009346Phase 1/2Results posted
• Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus IrinotecanTerminatedNCT01004159Phase 2Results posted
• Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00986674Phase 2Results posted
• Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT00971932Phase 2Results posted
• Preoperative Treatment With Cetuximab and/or IMC-A12CompletedNCT00957853Phase 2Results posted
• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck CancerActive, not recruitingNCT00956007Phase 3Results posted
• S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerTerminatedNCT00946712Phase 3Results posted
• Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)TerminatedNCT00904345Phase 2Results posted
• Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck CancerTerminatedNCT00891904Not applicableResults posted
• A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung CancerCompletedNCT00867009Phase 2Results posted
• Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT00865098Phase 2Results posted
• Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric CancerCompletedNCT00857246Phase 2Results posted
• Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck CancerCompletedNCT00851877Phase 1/2Results posted
• Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryTerminatedNCT00835679Early Phase 1Results posted
• Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck CancerCompletedNCT00833261Phase 2Results posted
• Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)CompletedNCT00820755Phase 3Results posted
• Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell CarcinomaCompletedNCT00815308Phase 2Results posted
• Study of Sorafenib/Cetuximab in Head and Neck CancerCompletedNCT00815295Phase 1/2Results posted
• A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the LiverCompletedNCT00803647Phase 2Results posted
• Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal CancerTerminatedNCT00766142Phase 2Results posted
• Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck CancerCompletedNCT00736944Phase 2Results posted
• Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00721513Phase 2Results posted
• Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to ErlotinibCompletedNCT00716456Phase 1/2Results posted
• Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With ChemoradiotherapyCompletedNCT00700440Phase 2Results posted
• Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid TumorsCompletedNCT00698841Phase 2Results posted
• Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior TherapyTerminatedNCT00694603Phase 2Results posted
• S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal CancerCompletedNCT00686166Phase 2Results posted
• Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric CancerCompletedNCT00678535Phase 3Results posted
• Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)CompletedNCT00673738Phase 2Results posted
• Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck CancerCompletedNCT00671437Phase 2Results posted
• Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx CancerCompletedNCT00665392Phase 2Results posted
• Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)CompletedNCT00661492Phase 2Results posted
• Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell CancerCompletedNCT00661427Phase 2Results posted
• Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00655876Phase 3Results posted
• Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial CancerCompletedNCT00645593Phase 2Results posted
• Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast CancerCompletedNCT00633464Phase 2Results posted
• Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and NeckCompletedNCT00617734Phase 2Results posted
• Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerTerminatedNCT00611858Phase 2Results posted
• Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)TerminatedNCT00599131Phase 2Results posted
• Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerTerminatedNCT00591149Phase 2Results posted
• Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of RectumTerminatedNCT00580073Phase 2Results posted
• Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and NeckTerminatedNCT00570674Phase 1/2Results posted

← Cetuximab overview